Pro Share Advisors LLC Allogene Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

$46.4 Billion
Q3 2025

A detailed history of Pro Share Advisors LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 33,830 shares of ALLO stock, worth $41,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,830

Previous 39,260 13.83%

Holding current value

$41,610

Previous $44,000 6.82%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$1.03 - $1.66 $5,592 - $9,013	-5,430 Reduced 13.83%	33,830 $41,000
Q2 2025 Aug 07, 2025	BUY	$0.95 - $1.7 $1,913 - $3,423	2,014 Added 5.41%	39,260 $44,000
Q1 2025 May 08, 2025	SELL	$1.4 - $2.84 $12,370 - $25,094	-8,836 Reduced 19.17%	37,246 $54,000
Q4 2024 Feb 13, 2025	BUY	$1.84 - $3.22 $17,273 - $30,229	9,388 Added 25.58%	46,082 $98,000
Q3 2024 Nov 13, 2024	BUY	$2.08 - $3.5 $23,189 - $39,021	11,149 Added 43.64%	36,694 $102,000

Q2 2024 Aug 13, 2024	SELL	$2.23 - $4.38 $7,189 - $14,121	-3,224 Reduced 11.21%	25,545 $59,000
Q1 2024 May 08, 2024	BUY	$2.92 - $5.63 $6,940 - $13,382	2,377 Added 9.01%	28,769 $128,000
Q4 2023 Feb 14, 2024	BUY	$2.28 - $3.5 $10,850 - $16,656	4,759 Added 22.0%	26,392 $84,000
Q3 2023 Nov 13, 2023	BUY	$3.17 - $5.96 $4,783 - $8,993	1,509 Added 7.5%	21,633 $68,000
Q2 2023 Aug 10, 2023	BUY	$4.53 - $6.74 $3,288 - $4,893	726 Added 3.74%	20,124 $100,000
Q1 2023 May 11, 2023	SELL	$4.92 - $8.21 $13,692 - $22,848	-2,783 Reduced 12.55%	19,398 $95,000
Q4 2022 Feb 02, 2023	BUY	$5.62 - $11.11 $7,289 - $14,409	1,297 Added 6.21%	22,181 $139,000
Q3 2022 Nov 04, 2022	SELL	$10.32 - $17.28 $4,902 - $8,208	-475 Reduced 2.22%	20,884 $225,000
Q2 2022 Aug 01, 2022	SELL	$6.78 - $12.28 $53,304 - $96,545	-7,862 Reduced 26.91%	21,359 $243,000
Q1 2022 May 10, 2022	SELL	$7.65 - $15.29 $57,788 - $115,500	-7,554 Reduced 20.54%	29,221 $266,000
Q4 2021 Feb 08, 2022	SELL	$13.13 - $24.52 $53,334 - $99,600	-4,062 Reduced 9.95%	36,775 $549,000
Q3 2021 Nov 12, 2021	SELL	$21.01 - $27.64 $97,465 - $128,221	-4,639 Reduced 10.2%	40,837 $1.05 Million
Q2 2021 Aug 13, 2021	BUY	$23.49 - $35.8 $243,473 - $371,066	10,365 Added 29.52%	45,476 $1.19 Million
Q1 2021 May 14, 2021	BUY	$25.79 - $39.02 $8,562 - $12,954	332 Added 0.95%	35,111 $1.24 Million
Q4 2020 Feb 09, 2021	BUY	$25.24 - $43.45 $116,785 - $201,043	4,627 Added 15.35%	34,779 $878,000
Q3 2020 Nov 13, 2020	BUY	$32.38 - $44.96 $80,723 - $112,085	2,493 Added 9.01%	30,152 $1.14 Million
Q2 2020 Aug 03, 2020	BUY	$18.39 - $54.04 $140,996 - $414,324	7,667 Added 38.35%	27,659 $1.18 Million
Q1 2020 May 15, 2020	SELL	$18.22 - $28.25 $234,126 - $363,012	-12,850 Reduced 39.13%	19,992 $389,000
Q4 2019 Feb 12, 2020	BUY	$24.82 - $31.4 $815,138 - $1.03 Million	32,842 New	32,842 $853,000

Others Institutions Holding ALLO

# of Institutions

182

Shares Held

138M

Call Options Held

76.6K

Put Options Held

36.2K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $177M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Allogene Therapeutics, Inc. Transaction History